sorafenib has been researched along with Corneal Angiogenesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, Z; Lu, P; Luo, Q; Pu, G; Shi, J; Xu, H; Yang, J; Zhang, J; Zhang, R; Zhao, N | 1 |
| Aydemir, O; Balbaba, M; İlhan, N; Özercan, İH; Yildirim, H | 1 |
| Choi, JS; Chung, SH; Joo, CK; Seo, JW | 1 |
3 other study(ies) available for sorafenib and Corneal Angiogenesis
| Article | Year |
|---|---|
Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development,
Topics: Animals; Cornea; Corneal Neovascularization; Drug Carriers; Lipids; Mice; Rabbits; Sorafenib | 2022 |
Comparison of the effect of topical bevacizumab and sorafenib in experimental corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Cornea; Corneal Neovascularization; Disease Models, Animal; Male; Protein Kinase Inhibitors; Rats, Wistar; Sorafenib; Vascular Endothelial Growth Factor A | 2020 |
Inhibition of corneal neovascularization in rats by systemic administration of sorafenib.
Topics: Administration, Oral; Animals; Benzenesulfonates; Blotting, Western; Corneal Neovascularization; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Male; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sorafenib; Vascular Endothelial Growth Factor Receptor-2 | 2012 |